CSat Investment Advisory’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$49K Buy
443
+30
+7% +$3.26K 0.04% 200
2020
Q4
$41K Sell
413
-459
-53% -$42.6K 0.04% 184
2020
Q3
$68K Sell
872
-39
-4% -$2.94K 0.01% 610
2020
Q2
$64K Buy
911
+170
+23% +$10.7K 0.01% 629
2020
Q1
$34K Buy
741
+1
+0.1% +$64 0.01% 620
2019
Q4
$59K Buy
740
+20
+3% +$1.54K 0.02% 569
2019
Q3
$53K Buy
720
+68
+10% +$4.88K 0.02% 512
2019
Q2
$50K Buy
652
+321
+97% +$24.4K 0.02% 522
2019
Q1
$25K Sell
331
-18
-5% -$1.43K 0.01% 262
2018
Q4
$26K Buy
349
+194
+125% +$15.5K 0.02% 216
2018
Q3
$15K Buy
155
+53
+52% +$5.25K 0.01% 278
2018
Q2
$10K Buy
+102
New +$10.8K 0.01% 343

Other funds holding EMN

CSat Investment Advisory's EMN Position: Q1 2021 in Review

CSat Investment Advisory increased its Eastman Chemical (EMN) stake by 7.3% in Q1 2021, buying an estimated $3.26K and bringing the position to 443 shares worth $49K. The position accounts for 0.04% of the portfolio, ranked #200.

CSat Investment Advisory first reported a position in EMN in Q2 2018 and has held it in 12 quarters since. The position peaked at $68K in Q3 2020. 731 funds tracked by Wall St. Rank hold EMN as of Q1 2021.

  • CSat Investment Advisory held 443 shares of Eastman Chemical worth $49K as of Q1 2021.
  • CSat Investment Advisory bought 30 Eastman Chemical shares in Q1 2021, an estimated $3.26K.
  • Eastman Chemical made up 0.04% of CSat Investment Advisory's portfolio in Q1 2021, its #200 holding.
  • CSat Investment Advisory first reported a position in Eastman Chemical in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's Eastman Chemical position peaked at $68K in Q3 2020.
  • 731 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.